With recent news about SGLT2s and GLP-1 RAs helping to protect against heart disease in addition to their primary purpose of lowering blood sugars, Dr. Edelman addresses the question of whether it’s safe to take them together, and if they can also cause hypoglycemia.
read more →With newer medication options available now for treating type 2 diabetes, Dr. Edelman answers a common question about how they can be included in a diabetes management regimen with regard to metformin.
read more →Did you know that certain aspects of type 2 diabetes can change over time? Even if you’ve had years of great blood sugar control, you still may need to make some medication adjustments down the road, and that’s totally normal.
read more →Heart disease is a common and serious condition for people with diabetes, but with the information, tools and medications we have available today, heart disease is not only treatable but preventable.
read more →Jeremy Pettus explains the pros and cons of SGLT2s for people with type 1, and offers advice on how to try them safely and smartly.
read more →The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
read more →SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →